Glucocorticoids and the regulation of growth hormone secretion (Q38079133)

28 August 2017

1 reference

title

Glucocorticoids and the regulation of growth hormone secretion (English)

1 reference

28 August 2017

2

Andrea Giustina

1 reference

28 August 2017

Gherardo Mazziotti

1

1 reference

PubMed ID

23381030

28 August 2017

language of work or name

1 reference

5 February 2013

1 reference

Nature Reviews Endocrinology

28 August 2017

1 reference

28 August 2017

9

1 reference

28 August 2017

265-276

1 reference

28 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2013.5

28 August 2017

0 references

cites work

Diagnosis and complications of Cushing's syndrome: a consensus statement.

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

The hidden but positive role for glucocorticoids in the regulation of growth hormone-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Biologic activities of growth hormone secretagogues in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Influence of thyroid hormones on the regulation of growth hormone secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Gene regulation by steroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Insights into hormonal control of messenger RNA stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Differential regulation of the growth hormone receptor gene: effects of dexamethasone and estradiol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Regulation of hypothalamic somatostatin, growth hormone-releasing hormone, and growth hormone receptor messenger ribonucleic acid by glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

The glucocorticoid receptor and its expression in the anterior pituitary and the adrenal cortex: a source of variation in hypothalamic-pituitary-adrenal axis function; implications for pituitary and adrenal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Genome-wide analysis of glucocorticoid receptor-binding sites in myotubes identifies gene networks modulating insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

A substitution in the ligand binding domain of the porcine glucocorticoid receptor affects activity of the adrenal gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Glucocorticoid receptor colocalization with pituitary hormones in the rat pituitary gland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Administration of adrenocorticotropic hormone during chicken embryonic development prematurely induces pituitary growth hormone cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Functional maturation of growth hormone cells in the anterior pituitary gland of the fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Regulation of chicken embryonic growth hormone secretion by corticosterone and triiodothyronine: evidence for a negative synergistic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Transgenic mice expressing the human growth hormone gene provide a model system to study human growth hormone synthesis and secretion in non-tumor-derived pituitary cells: differential effects of dexamethasone and thyroid hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Glucocorticoid and thyroid hormones transcriptionally regulate growth hormone gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Growth Hormone Secretion by Cultured Rat Anterior Pituitary Cells. Effects of Culture Conditions and Dexamethasone*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Dexamethasone increases growth hormone (GH)-releasing hormone (GRH) receptor mRNA levels in cultured rat anterior pituitary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Glucocorticoids regulate pituitary growth hormone secretagogue receptor gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Immunocytochemical and molecular analysis of the effects of glucocorticoid treatment on the hypothalamic-somatotropic axis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Glucocorticoid regulation of growth hormone (GH) secretagogue-induced growth responses and GH secretagogue receptor expression in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Growth hormone-releasing factor binding sites in rat anterior pituitary membrane homogenates: modulation by glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Binding sites for growth hormone releasing factor on rat anterior pituitary cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Role of glucocorticoids in the regulation of pituitary somatostatin receptor subtype (sst1-sst5) mRNA levels: evidence for direct and somatostatin-mediated effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Potent interaction between glucocorticoids and growth hormone-releasing factor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Studies on the Mechanism of Pentobarbital-Induced GH Release in the Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Glucocorticoid inhibition of growth in rats: partial reversal with somatostatin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

The somatostatin subtype-2 receptor antagonist, BIM-23627, improves the catabolic effects induced by long-term glucocorticoid treatment in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Glucocorticoid inhibition of growth in rats: partial reversal with the full-length ghrelin analog BIM-28125.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Growth hormone and growth hormone secretagogue effects on nitrogen balance and urea synthesis in steroid treated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Relation between growth hormone and cortisol spontaneous secretion in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Dose-dependent inhibition of growth hormone (GH)-releasing hormone-induced GH release by corticotropin-releasing hormone in prepubertal children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Effects of short-term glucocorticoid deprivation on growth hormone (GH) response to GH-releasing hormone in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Reports of two cases of selective adrenocorticotropin (ACTH) and growth hormone (GH) deficiency: differential diagnosis from cases with isolated ACTH deficiency associated with transient GH insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Neonatal complete generalized glucocorticoid resistance and growth hormone deficiency caused by a novel homozygous mutation in Helix 12 of the ligand binding domain of the glucocorticoid receptor gene (NR3C1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Deficiency of growth hormone in an adult man case of idiopathic adrenocorticotropin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Current guidelines for adult GH replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

GH replacement in adults: interactions with other pituitary hormone deficiencies and replacement therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Novel strategies for hydrocortisone replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Pyridostigmine-mediated growth hormone release: evidence for somatostatin involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Arginine blocks the inhibitory effect of hydrocortisone on circulating growth hormone levels in patients with acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Inhibition by prednisone of growth hormone (GH) response to GH-releasing hormone in normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Growth hormone response to growth hormone-releasing hormone is reduced in adult asthmatic patients receiving long-term inhaled corticosteroid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Effects of pyridostigmine on spontaneous and growth hormone-releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Glucocorticoids may inhibit growth hormone release by enhancing beta-adrenergic responsiveness in hypothalamic somatostatin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Effect of withdrawal of somatostatin plus growth hormone (GH)-releasing hormone as a stimulus of GH secretion in Cushing's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Cardiovascular risk in aging and obesity: is there a role for GH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Mechanisms of steroid impairment of growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Growth hormone increases final height in patients with juvenile idiopathic arthritis: data from a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency: in early infancy and (pre)puberty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Daily or intermittent budesonide in preschool children with recurrent wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Inhaled corticosteroids and asthma control in children: assessing impairment and risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Growth hormone treatment in children on chronic glucorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Efficacy and safety of one year of growth hormone therapy in steroid-dependent nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Growth hormone improves height in patients with juvenile idiopathic arthritis: 4-year data of a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Growth hormone treatment in children with rheumatic disease, corticosteroid induced growth retardation, and osteopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Early recombinant human growth hormone treatment in glucocorticoid-treated children with juvenile idiopathic arthritis: a 3-year randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Growth hormone changes bone geometry and body composition in patients with juvenile idiopathic arthritis requiring glucocorticoid treatment: a controlled study using peripheral quantitative computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Drug-induced osteoporosis: mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Glucocorticoid-induced osteoporosis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Growth hormone, insulin-like growth factors, and the skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

New understanding and treatments for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Mechanisms of anabolic therapies for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Bone ultrasonometric features and growth hormone secretion in asthmatic patients during chronic inhaled corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Thigh muscle mass and function in patients treated with glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Human growth hormone prevents the protein catabolic side effects of prednisone in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Growth hormone and lean tissue catabolism during long-term glucocorticoid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Impact of growth hormone and dehydroepiandrosterone on protein metabolism in glucocorticoid-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

A single dose of cilazapril improves diastolic function in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Clinical review: Growth hormone and cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Moderate deterioration in glucose tolerance during high-dose growth hormone therapy in glucocorticoid-treated patients with juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Diabetes in Cushing syndrome: basic and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Glucose metabolism in patients with subclinical Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Cardiovascular risk in Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Successful treatment of childhood-onset Cushing's disease is associated with persistent reduction in growth hormone secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Growth hormone status following treatment for Cushing's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Treatment of Cushing disease: overview and recent findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Clinical features of GH deficiency and effects of 3 years of GH replacement in adults with controlled Cushing's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Growth in disorders of adrenal hyperfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

The role of glucocorticoids in the regulation of Growth Hormone secretion: mechanisms and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Dexamethasone inhibits growth hormone induction of insulin-like growth factor-I (IGF-I) messenger ribonucleic acid (mRNA) in hypophysectomized rats and reduces IGF-I mRNA abundance in the intact rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Modulation of glucocorticoid metabolism by the GH-IGF-I axis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Induction of somatotroph differentiation in vivo by corticosterone administration during chicken embryonic development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Thyroid hormone and glucocorticoid regulation of pituitary growth hormone-releasing hormone receptor gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Glucocorticoids regulate pituitary growth hormone-releasing hormone receptor messenger ribonucleic acid expression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Corticosterone modulates growth hormone-releasing factor and somatostatin in fetal rat hypothalamic cultures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Effect of GHRP-6 and GHRH on GH secretion in rats following chronic glucocorticoid treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Adrenergic and cholinergic involvement in basal and growth hormone-releasing hormone-stimulated growth hormone secretion in glucocorticoid-treated rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Galanin counteracts the inhibitory effects of glucocorticoids on growth hormone secretion in the rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Hypocortisolemia in children undergoing evaluation for growth hormone deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

The influence of serum cortisol levels on growth hormone responsiveness to GH-releasing hormone plus GH-releasing peptide-6 in patients with hypocortisolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Growth hormone (GH) secretion in primary adrenal insufficiency: effects of cortisol withdrawal and patterned replacement on GH pulsatility and circadian rhythmicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Isolated ACTH deficiency with transitory GH deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Growth hormone deficiency in patients with idiopathic adrenocorticotropin deficiency resolves during glucocorticoid replacement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Severe cortisol deficiency associated with reversible growth hormone deficiency in two infants: what is the link?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Acute effects of cortisone acetate on growth hormone response to growth hormone-releasing hormone in normal adult subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Effect of hydrocortisone on the growth hormone response to growth hormone-releasing hormone in acromegaly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Acute administration of corticoids: a new and peculiar stimulus of growth hormone secretion in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Dual and selective actions of glucocorticoids upon basal and stimulated growth hormone release in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Effect of galanin on the growth hormone (GH) response to GH-releasing hormone in patients with Cushing's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Pyridostigmine Enhances Even if it Does Not Normalize the Growth Hormone Responses to Growth Hormone-Releasing Hormone in Patients with Cushing&rsquo;s Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Glucocorticoid Action Networks—An Introduction to Systems Biology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Effects of growth hormone administration in pediatric renal allograft recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Juvenile rheumatoid arthritis. Effects of disease activity and recombinant human growth hormone on insulin-like growth factor 1, insulin-like growth factor binding proteins 1 and 3, and osteocalcin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Treatment of glucocorticoid-induced growth suppression with growth hormone. National Cooperative Growth Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Growth hormone treatment of short stature and metabolic dysfunction in juvenile chronic arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

GH therapy in juvenile chronic arthritis: results of a two-year controlled study on growth and bone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Dynamics of body composition and bone in patients with juvenile idiopathic arthritis treated with growth hormone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Growth hormone can reverse glucocorticoid-induced low bone turnover on cortical but not on cancellous bone surfaces in adult Wistar rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Effects of IGF-I combined with GH on glucocorticoid-induced changes of bone and connective tissue turnover in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Altered body fat distribution in patients with glucocorticoid treatment and in patients on long-term dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Metabolic, Cardiovascular, and Cerebrovascular Outcomes in Growth Hormone-Deficient Subjects with Previous Cushing’s Disease or Non-Functioning Pituitary Adenoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.5

Modulation of glucocorticoid metabolism by the growth hormone - IGF-1 axis

31 March 2020

1 reference

12 December 2020

Treatment of growth retardation in juvenile chronic arthritis with recombinant human growth hormone

1 reference

12 December 2020

Physiological hypercortisolemia increases proteolysis, glutamine, and alanine production

1 reference

12 December 2020

Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure.

1 reference

12 December 2020

Long-term outcome in children and adolescents after transsphenoidal surgery for Cushing's disease

1 reference

12 December 2020

Recombinant human growth hormone improves growth in children receiving glucocorticoid treatment after liver transplantation

1 reference

12 December 2020

Effects on growth and body composition of growth hormone treatment in children with juvenile idiopathic arthritis requiring steroid therapy.

1 reference

12 December 2020

The effect of recombinant human growth hormone on glucose and leucine metabolism in Cushing's syndrome

1 reference

12 December 2020

Stimulation of collagen synthesis and linear growth by growth hormone in glucocorticoid-treated children

1 reference

12 December 2020

Arginine normalizes the growth hormone (GH) response to GH-releasing hormone in adult patients receiving chronic daily immunosuppressive glucocorticoid therapy

1 reference

12 December 2020

Dichotomic action of glucocorticoids on growth hormone secretion

1 reference

12 December 2020

[Isolated ACTH deficiency and transient GH deficiency. Presentation of a case]

1 reference

12 December 2020

Spontaneous cortisol and growth hormone secretion interactions in patients with nonclassic 21-hydroxylase deficiency (NCCAH) and control children

1 reference

12 December 2020

Effects of recombinant human growth hormone (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone

1 reference

12 December 2020

Treatment of growth failure with human growth hormone in patients with juvenile chronic arthritis. A pilot study

1 reference

12 December 2020

Bone mass development and bone metabolism in juvenile idiopathic arthritis: treatment with growth hormone for 4 years

1 reference

12 December 2020

Hyperlipidemia after organ transplantation

1 reference

12 December 2020

Role of glucocorticoids in the neuroregulation of growth hormone secretion

1 reference

12 December 2020

Improved response of growth hormone to growth hormone-releasing hormone and reversible chronic thyroiditis after hydrocortisone replacement in isolated adrenocorticotropic hormone deficiency

1 reference

12 December 2020

Growth hormone deficiency, rapidly reversible during glucocorticoid replacement, in a case of adrenocorticotrophin deficiency

1 reference

12 December 2020

Metabolic effects of recombinant human insulin-like growth factor-I in humans: comparison with recombinant human growth hormone

1 reference

12 December 2020

Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids

1 reference

12 December 2020

Effects of short-term glucocorticoid deprivation on growth hormone (GH) response to GH-releasing peptide-6: studies in normal men and in patients with adrenal insufficiency

1 reference

12 December 2020

Linear growth and final height after treatment for Cushing's disease in childhood.

1 reference

12 December 2020

Treatment of juvenile rheumatoid arthritis with growth hormone

1 reference

12 December 2020

Cortisol and growth hormone: clinical implications of a complex, dynamic relationship.

1 reference

12 December 2020

Reciprocal relationship between the level of circulating cortisol and growth hormone secretion in response to growth hormone-releasing hormone in man: studies in patients with adrenal insufficiency

1 reference

12 December 2020

Effects of sex and age on the growth hormone response to galanin in healthy human subjects

1 reference

12 December 2020

Beneficial effects of one-year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy. I. Effects on growth velocity and body composition

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2013.5

1 reference

PubMed ID

23381030

Dimensions Publication ID

28 August 2017

0 references

1 reference

PubMed ID

23381030